SARDA PROTEINS LTD.

Fresita Proteins Ltd has announced a Board of Directors meeting scheduled for October 26, 2026. The primary agenda is to finalize terms for a Rights Issue of equity shares, approved earlier for an amount not exceeding Rs. 90 Crore. The meeting will determine the Rights Issue price, payment mechanism, entitlement ratio, record date, and timing. Concurrently, the company has closed its trading window for directors and designated persons from October 26, 2026, until 48 hours after the board meeting concludes, in line with its insider trading code.

Fresita Proteins Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This restriction will be in effect from October 1, 2026, until 48 hours after the declaration of the company's Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The closure is in compliance with SEBI's insider trading regulations. The date for the board meeting to approve these financial results will be communicated separately.

Sarda Proteins Limited has responded to stock exchange queries regarding recent price movements in its securities. The company stated that it has complied with all disclosure requirements under SEBI LODR Regulations and there are no material events, information, or impending announcements that have not been disclosed. Sarda Proteins attributes the price and volume fluctuations to market forces, including prevailing market conditions, demand-supply dynamics, investor sentiment, and macroeconomic factors, which are beyond the company's control. They confirmed no undisclosed corporate development is known to have caused the recent stock activity.

Sarda Proteins Ltd has responded to a clarification request regarding significant price movement in its securities. The company stated that it adheres to its Corporate Governance Code for disseminating price-sensitive information and business updates. It believes the recent price fluctuations are driven by market forces and general market conditions. All required disclosures under SEBI Listing Regulations are made promptly upon Board decisions and the occurrence of reportable events.

Sarda Proteins Ltd has officially changed its name to Fresita Proteins Limited, effective August 21, 2026, as approved by the Ministry of Corporate Affairs (MCA). The Bombay Stock Exchange (BSE) has also approved the new name and will implement a new Scrip ID, 'FRESITA', effective September 21, 2026. The company is completing formalities with depositories (NSDL and CDSL) to update its records. This name change does not affect stakeholder rights or liabilities, though the company must display its old name alongside the new one for two years.

Sarda Proteins Ltd has filed its 35th Annual Report for FY 2025-26. The report highlights a significant capital event where over ₹83 crore in fresh equity was introduced through warrant conversions by the Promoter Group, transferring control to Onix Renewable Limited. This led to a substantial increase in net worth from ₹2.38 crore to ₹86.21 crore. Operationally, revenue from the legacy trading business declined by 33.3% to ₹16.14 crore. However, profitability saw an improvement from a low base, with profit before tax rising to ₹63.51 lakh and profit after tax to ₹45.44 lakh, partly supported by other income. The company has also expanded its business objects to include agriculture, horticulture, and food processing, and has approved a rights issue of up to ₹90 crore, with a significant portion earmarked for acquiring stakes in Fresita Food Private Limited and Urja Protein India Private Limited, signaling a strategic shift towards becoming an agri-food group.

Sarda Proteins Ltd has announced its 35th Annual General Meeting (AGM) to be held on Wednesday, September 30, 2026, at 11:00 AM IST. The meeting will be conducted through Video Conferencing (VC) or other Audio Visual Means (OAVM). Key agenda items include the adoption of standalone audited financial statements for the financial year ended March 31, 2026, the re-appointment of Mr. Shivam Gunvantray Zaladi as a Director, and the appointment of M/s. A H Mandaliya & Associates as Statutory Auditors for a term of five years. The company also plans to seek approval for borrowing powers up to ₹1,000 crore.

Sarda Proteins Limited has announced that its 35th Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 11:00 AM IST via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The Board of Directors approved this decision on September 7, 2026. For the purpose of the AGM, the company's Register of Members and Share Transfer Books will be closed from September 24, 2026, to September 30, 2026, inclusive. The cut-off date for determining voting eligibility (remote e-voting and e-voting at the AGM) has been fixed as Wednesday, September 23, 2026. Remote e-voting will be open from September 26, 2026, 9:00 AM IST to September 29, 2026, 5:00 PM IST.

Sarda Proteins Limited has announced that its 35th Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 11:00 AM IST via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The Board of Directors approved this during their meeting on September 7, 2026. The company has also fixed Wednesday, September 23, 2026, as the cut-off date for determining voting eligibility. The register of members and share transfer books will be closed from September 24 to September 30, 2026, inclusive, for the AGM. Remote e-voting will be open from September 26 to September 29, 2026.

Sarda Proteins Ltd announced that its Board of Directors, in a meeting held on September 7, 2026, approved convening the Annual General Meeting (AGM) on September 30, 2026. The AGM will be held through Video Conferencing/Other Audio Visual Means. The Board also approved the Notice of AGM, closure of the Register of Members and Share Transfer Books from September 24 to September 30, 2026, and set September 23, 2026, as the cut-off date for e-voting. The remote e-voting period is scheduled from September 26 to September 29, 2026. Mr. Himansu Togadiya was appointed as the Scrutinizer, and arrangements were made with MUFG Intime India Private Limited for e-voting and video conferencing facilities.